Size exclusion chromatography as green support for forced degradation study of adalimumab
Size exclusion chromatography (SEC) has become a powerful tool for analysing size variants of biologic drugs in their native form. Modern SEC can be defined by the use of chromatographic columns packed with sub-3 µm particles, allowing an increase in method throughput compared to that of conventiona...
Main Authors: | Kovačić Jelena, Klarić Daniela Amidžić, Turk Nikša, Mornar Ana |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2023-12-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.2478/acph-2023-0044 |
Similar Items
-
Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease
by: Mario-Livio Jeličić, et al.
Published: (2022-08-01) -
The Past, the Present, and the Future of the Size Exclusion Chromatography in Extracellular Vesicles Separation
by: Hussein Kaddour, et al.
Published: (2021-11-01) -
Isolation and Quantification of Polystyrene Nanoplastics in Tissues by Low Pressure Size Exclusion Chromatography
by: François Gagné
Published: (2022-05-01) -
Evaluation of Selected Cellulose Macromolecular Properties after Its Chemical Treatment Using Size Exclusion Chromatography
by: Tereza Jurczyková, et al.
Published: (2023-01-01) -
Pharmacokinetic Profiling and Simultaneous Determination of Thiopurine Immunosuppressants and Folic Acid by Chromatographic Methods
by: Edvin Brusač, et al.
Published: (2019-09-01)